Taurus Asset Management’s AbbVie ABBV Stock Holding History

Taurus Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$1.29M	Sell	6,157 -25	-0.4%	-$4.86K	0.13%	52
2024 Q4	$1.1M	Hold	6,182	–	–	0.11%	54
2024 Q3	$1.22M	Hold	6,182	–	–	0.12%	53
2024 Q2	$1.06M	Sell	6,182 -125	-2%	-$20.7K	0.11%	55
2024 Q1	$1.15M	Sell	6,307 -950	-13%	-$164K	0.12%	52
2023 Q4	$1.12M	Hold	7,257	–	–	0.12%	49
2023 Q3	$1.08M	Sell	7,257 -825	-10%	-$121K	0.13%	48
2023 Q2	$1.09M	Hold	8,082	–	–	0.13%	49
2023 Q1	$1.29M	Sell	8,082 -1,007	-11%	-$154K	0.16%	50
2022 Q4	$1.47M	Hold	9,089	–	–	0.19%	48
2022 Q3	$1.22M	Hold	9,089	–	–	0.16%	47
2022 Q2	$1.39M	Sell	9,089 -1,300	-13%	-$199K	0.17%	47
2022 Q1	$1.68M	Sell	10,389 -639	-6%	-$92.8K	0.17%	46
2021 Q4	$1.49M	Sell	11,028 -1,600	-13%	-$189K	0.14%	45
2021 Q3	$1.36M	Sell	12,628 -1,975	-14%	-$226K	0.14%	48
2021 Q2	$1.65M	Sell	14,603 -100	-0.7%	-$11.3K	0.17%	48
2021 Q1	$1.59M	Sell	14,703 -3,478	-19%	-$372K	0.18%	49
2020 Q4	$1.95M	Sell	18,181 -700	-4%	-$67.3K	0.23%	43
2020 Q3	$1.65M	Hold	18,881	–	–	0.2%	50
2020 Q2	$1.85M	Buy	18,881 +120	+0.6%	+$10.6K	0.26%	48
2020 Q1	$1.43M	Sell	18,761 -500	-3%	-$42.6K	0.24%	48
2019 Q4	$1.71M	Sell	19,261 -400	-2%	-$33.2K	0.22%	52
2019 Q3	$1.49M	Hold	19,661	–	–	0.21%	51
2019 Q2	$1.43M	Sell	19,661 -34,197	-63%	-$2.69M	0.19%	51
2019 Q1	$4.34M	Sell	53,858 -531	-1%	-$43.4K	0.61%	43
2018 Q4	$5.01M	Sell	54,389 -378	-0.7%	-$33.2K	0.8%	41
2018 Q3	$5.18M	Hold	54,767	–	–	0.7%	47
2018 Q2	$5.07M	Sell	54,767 -416	-0.8%	-$40.6K	0.74%	46
2018 Q1	$5.22M	Sell	55,183 -2,229	-4%	-$245K	0.79%	46
2017 Q4	$5.55M	Sell	57,412 -900	-2%	-$84.8K	0.82%	44
2017 Q3	$5.18M	Buy	58,312 +860	+1%	+$65.5K	0.81%	46
2017 Q2	$4.17M	Sell	57,452 -300	-0.5%	-$20.2K	0.65%	48
2017 Q1	$3.76M	Sell	57,752 -3,200	-5%	-$201K	0.62%	47
2016 Q4	$3.82M	Sell	60,952 -100	-0.2%	-$6.1K	0.69%	44
2016 Q3	$3.85M	Sell	61,052 -2,000	-3%	-$129K	0.7%	42
2016 Q2	$3.9M	Sell	63,052 -1,062	-2%	-$64.7K	0.69%	42
2016 Q1	$3.66M	Sell	64,114 -600	-0.9%	-$33.4K	0.68%	45
2015 Q4	$3.83M	Hold	64,714	–	–	0.72%	45
2015 Q3	$3.52M	Hold	64,714	–	–	0.68%	48
2015 Q2	$4.35M	Sell	64,714 -415	-0.6%	-$27.1K	0.79%	46
2015 Q1	$3.81M	Sell	65,129 -152	-0.2%	-$9.18K	0.71%	49
2014 Q4	$4.27M	Sell	65,281 -3,300	-5%	-$208K	0.77%	52
2014 Q3	$3.96M	Sell	68,581 -300	-0.4%	-$16.7K	0.77%	51
2014 Q2	$3.89M	Sell	68,881 -2,054	-3%	-$108K	0.75%	52
2014 Q1	$3.65M	Sell	70,935 -361	-0.5%	-$18.2K	0.76%	50
2013 Q4	$3.77M	Hold	71,296	–	–	0.78%	54
2013 Q3	$3.19M	Sell	71,296 -1,000	-1%	-$44.3K	0.74%	51
2013 Q2	$2.99M	Buy	+72,296	New	+$3.16M	0.71%	52

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Taurus Asset Management's ABBV Position: Q1 2025 in Review

Taurus Asset Management reduced its AbbVie (ABBV) stake by 0.4% in Q1 2025, selling an estimated $4.86K and leaving 6,157 shares worth $1.29M. The position accounts for 0.13% of the portfolio, ranked #52.

Taurus Asset Management first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $5.55M in Q4 2017. 3,820 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

Taurus Asset Management held 6,157 shares of AbbVie worth $1.29M as of Q1 2025.
Taurus Asset Management sold 25 AbbVie shares in Q1 2025, an estimated $4.86K.
AbbVie made up 0.13% of Taurus Asset Management's portfolio in Q1 2025, its #52 holding.
Taurus Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
Taurus Asset Management's AbbVie position peaked at $5.55M in Q4 2017.
3,820 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Taurus Asset Management's 13F filing for Q1 2025, filed 13 May 2025.